This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiz, M.
Right arrow Articles by Kurtis, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiz, M.
Right arrow Articles by Kurtis, J. D.

 Previous Article  |  Next Article 

Infection and Immunity, July 2008, p. 3164-3169, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00409-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Pilot-Scale Production and Characterization of Paramyosin, a Vaccine Candidate for Schistosomiasis Japonica{triangledown} ,{dagger}

Mario Jiz,1,2 Hai-Wei Wu,1,3* Rui Meng,3 Sunthorn Pond-Tor,1 Mindy Reynolds,2 Jennifer F. Friedman,1,4 Remigio Olveda,5 Luz Acosta,5 and Jonathan D. Kurtis1,6

Center for International Health Research,1 Department of Pediatrics,4 Department of Pathology and Laboratory Medicine, Rhode Island Hospital,6 Pathobiology Graduate Program, Brown University, Providence, Rhode Island,2 Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China,3 Research Institute for Tropical Medicine, Alabang, Muntinlupa City, Metro Manila, Philippines5

Received 2 April 2008/ Returned for modification 8 April 2008/ Accepted 14 April 2008

Despite effective chemotherapy, schistosomiasis remains a major public health problem in the developing world, with at least 200 million active infections resulting in significant morbidity. Rapid reinfection after treatment, accompanied by extensive residual morbidity, mandates alternative control strategies, including vaccine development. Paramyosin, a myofibrillar protein found only in invertebrates, has been widely studied as a vaccine candidate for both Schistosoma mansoni and Schistosoma japonicum. Recently, we demonstrated that Th2-biased immune responses to paramyosin are associated with resistance to reinfection with S. japonicum in humans; however, challenges in the pilot-scale production of schistosome paramyosin have hampered further studies of this promising vaccine candidate. Here we report a method for the pilot-scale expression and purification of recombinant S. japonicum paramyosin (rSj97). rSj97 was extracted from Escherichia coli inclusion bodies and purified with sequential anion-exchange, hydroxyapatite, and size exclusion chromatography. The purified rSj97 was >95% pure as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis and was free of significant endotoxin contamination. We demonstrate that, like native paramyosin, rSj97 adopts an alpha-helical coiled-coil tertiary structure and binds immunoglobulin and collagen. Naïve mice infected with S. japonicum produce anti-rSj97 immunoglobulin G (IgG) antibodies as early as 4 weeks postinfection, while sera collected from S. japonicum-infected individuals contain anti-rSj97 IgE antibodies. Our method for pilot-scale production of recombinant full-length paramyosin will facilitate preclinical evaluation of paramyosin as a vaccine for schistosomiasis.

* Corresponding author. Mailing address: Center for International Health Research, 55 Claverick St., Providence, RI 02903. Phone: (401) 444-7963. Fax: (401) 444-7854. E-mail: Haiwei_Wu{at}brown.edu

{triangledown} Published ahead of print on 21 April 2008.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: W. A. Petri, Jr.

Infection and Immunity, July 2008, p. 3164-3169, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00409-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Jiz, M., Friedman, J. F., Leenstra, T., Jarilla, B., Pablo, A., Langdon, G., Pond-Tor, S., Wu, H.-W., Manalo, D., Olveda, R., Acosta, L., Kurtis, J. D. (2009). Immunoglobulin E (IgE) Responses to Paramyosin Predict Resistance to Reinfection with Schistosoma japonicum and Are Attenuated by IgG4. Infect. Immun. 77: 2051-2058 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»